Head circumferences of children born to HIV-infected and HIV-uninfected mothers in Zimbabwe during the preantiretroviral therapy era

AIDS

Volumn 30, Issue 15, 2016, Pages 2323-2328

  Evans, Ceri ^a,b   Chasekwa, Bernard ^a   Ntozini, Robert ^a   Humphrey, Jean H ^a,c   Prendergast, Andrew J ^a,b,c  

^a Zvitambo Institute for Maternal and Child Health Research   (Zimbabwe)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Africa; children; head circumference; HIV; microcephaly

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAD CIRCUMFERENCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTRAPARTUM CARE; INTRAUTERINE GROWTH RETARDATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROCEPHALY; NEUROANATOMY; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; ZIMBABWE; ANATOMY AND HISTOLOGY; ANTHROPOMETRY; CHILD DEVELOPMENT; FETOMATERNAL TRANSFUSION; HEAD; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PRESCHOOL CHILD;

ANTHROPOMETRY; CHILD DEVELOPMENT; CHILD, PRESCHOOL; FEMALE; HEAD; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; MATERNAL-FETAL EXCHANGE; MICROCEPHALY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; ZIMBABWE;

EID: 84978759458     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001196     Document Type: Article

References (25)

1. Marinda E,Humphrey JH, Iliff PJ,Mutasa K,Nathoo KJ, Piwoz EG, et al. Childmortality according tomaternal and infant HIVstatus in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-526.
2. Evans C, Jones CE, Prendergast AJ. HIV-exposed, uninfected infants: new challenges in the era of paediatric HIV elimination. Lancet Infect Dis 2016; 16:e92-e107.
3. Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, et al. Morbidity among human immunodeficiency virusexposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011; 30:45-51.
4. Le Doaré K, Bland R, Newell ML. Neurodevelopment in children born to HIV-infected mothers by infection and treatment status. Pediatrics 2012; 130:e1326-e1344.
5. Cheong JL, Hunt RW, Anderson PJ, Howard K, Thompson DK, Wang HX, et al. Head growth in preterm infants: Correlation with magnetic resonance imaging and neurodevelopmental outcome. Pediatrics 2008; 121:e1534-e1540.
6. Kandawasvika GQ, Ogundipe E, Gumbo FZ, Kurewa EN, Mapingure MP, Stray-Pedersen B. Neurodevelopmental impairment among infants born to mothers infected with human immunodeficiency virus and uninfected mothers from three peri-urban primary care clinics in Harare, Zimbabwe. Dev Med Child Neurol 2011; 53:1046-1052.
7. Epstein LG, Gelbard HA. HIV-1-induced neuronal injury in the developing brain. J Leukoc Biol 1999; 65:453-457.
8. Humphrey JH, Iliff PJ, Marinda ET, Mutasa K, Moulton LH, Chidawanyika H, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis 2006; 193:860-871.
9. Malaba LC, Iliff PJ, Nathoo KJ, Marinda E, Moulton LH, Zijenah LS, et al. Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe. Am J Clin Nutr 2005; 81:454-460.
10. Gibson RS. Principles of nutritional assessment. New York: Oxford University Press; 1990.
11. WHO. WHO child growth standards: Methods and development. 2006, http://www.who.int/childgrowth/publications/technical- report-pub/en/index.html [accessed 15th September 2015].
12. Lepage P, Msellati P, Hitimana DG, Bazubagira A, Van Goethem C, Simonon A, et al. Growth of human immunodeficiency type 1-infected and uninfected children: A prospective cohort study in Kigali, Rwanda, 1988 to 1993. Pediatr Infect Dis J 1996; 15:479-485.
13. Moye J Jr, Rich KC, Kalish LA, Sheon AR, Diaz C, Cooper ER, et al. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. Women and Infants Transmission Study Group. J Pediatr 1996; 128: 58-69.
14. Neubauer V, Griesmaier E, Pehböck-Walser N, Pupp-Peglow U, Kiechl-Kohlendorfer U. Poor postnatal head growth in very preterm infants is associated with impaired neurodevelopment outcome. Acta Paediatr 2013; 102:883-888.
15. Macmillan C, Magder LS, Brouwers P, Chase C, Hittelman J, Lasky T, et al. Head growth and neurodevelopment of infants born to HIV-1-infected drug-using women. Neurology 2001; 57:1402-1411.
16. Becquet R, Marston M, Dabis F, Moulton LH, Gray G, Coovadia HM, et al. Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: A meta-analysis. PLoS One 2012; 7:e28510.
17. Smith R, Malee K, Charurat M, Magder L, Mellins C, Macmillan C, et al. Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Women and Infant Transmission Study Group. Pediatr Infect Dis J 2000; 19:862-871.
18. Gómez C, Archila ME, Rugeles C, Carrizosa J, Rugeles MT, Cornejo JW. A prospective study of neurodevelopment of uninfected children born to human immunodeficiency virus type 1 positive mothers. Rev Neurol 2009; 48:287-291.
19. Neri D, Somarriba GA, Schaefer NN, Chaparro AI, Scott GB, Lopez Mitnik G, et al. Growth and body composition of uninfected children exposed to human immunodeficiency virus: Comparison with a contemporary cohort and United States national standards. J Pediatr 2013; 163:249-254.
20. Jahanshad N, Couture MC, Prasitsuebsai W, Nir TM, Aurpibul L, Thompson PM, et al. Brain imaging and neurodevelopment in HIV-uninfected Thai children born to HIV-infected mothers. Pediatr Infect Dis J 2015; 34:e211-e216.
21. Kerr SJ, Puthanakit T, Vibol U, Aurpibul L, Vonthanak S, Kosalaraksa P, et al. Neurodevelopmental outcomes in HIVexposed- uninfected children versus those not exposed to HIV. AIDS Care 2014; 26:1327-1335.
22. Shiau S, Arpadi S, Strehlau R, Martens L, Patel F, Coovadia A, et al. Initiation of antiretroviral therapy before 6 months of age is associated with faster growth recovery in South African children perinatally infected with human immunodeficiency virus. J Pediatr 2013; 162:1138-1145.
23. Siberry GK, Williams PL, Mendez H, Seage GR 3rd, Jacobson DL, Hazra R, et al. Safety of tenofovir use during pregnancy: Early growth outcomes in HIV-exposed uninfected infants. AIDS 2012; 26:1151-1159.
24. Jones AD, Rukobo S, Chasekwa B, Mutasa K, Ntozini R, Mbuya MN, et al. Acute illness is associated with suppression of the growth hormone axis in Zimbabwean infants. Am J Trop Med Hyg 2015; 92:463-470doi:10.4269/ajtmh.14-0448.
25. Gompels UA, Larke N, Sanz-Ramos M, Bates M, Musonda K, Manno D, et al. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIVexposed and unexposed infants in Zambia. Clin Infect Dis 2012; 54:434-442.